Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

The comprehensive treatment with biomimetic peptide lotion was effective for hair loss.

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Metronidazole can cause lung disease.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

New treatments for hair loss are promising.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Analyzing hair for its elemental makeup can be useful for diagnosis, but there are still challenges and room for improvement.

The article explains how to tell apart and treat two common causes of hair loss in women.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Hair loss in women was often caused by stress, illness, childbirth, or low hemoglobin, with most cases being telogen effluvium.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Spironolactone improved hair density and quality in women with hair loss.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

Women with mixed alopecia have more severe mental health issues than those with metabolic alopecia.

Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.